BR112016012393A2 - Vacina, e, uso de uma combinação de um vírus prrs atenuado vivo e um antígeno de lawsonia intracellularis inativado - Google Patents

Vacina, e, uso de uma combinação de um vírus prrs atenuado vivo e um antígeno de lawsonia intracellularis inativado

Info

Publication number
BR112016012393A2
BR112016012393A2 BR112016012393A BR112016012393A BR112016012393A2 BR 112016012393 A2 BR112016012393 A2 BR 112016012393A2 BR 112016012393 A BR112016012393 A BR 112016012393A BR 112016012393 A BR112016012393 A BR 112016012393A BR 112016012393 A2 BR112016012393 A2 BR 112016012393A2
Authority
BR
Brazil
Prior art keywords
vaccine
lawsonia intracellularis
combination
prrs virus
live
Prior art date
Application number
BR112016012393A
Other languages
English (en)
Other versions
BR112016012393A8 (pt
Inventor
Drexler Christa
Arnoldus Christiaan Jacobs Antonius
Original Assignee
Intervet Int Bv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=49680927&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=BR112016012393(A2) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Intervet Int Bv filed Critical Intervet Int Bv
Publication of BR112016012393A2 publication Critical patent/BR112016012393A2/pt
Publication of BR112016012393A8 publication Critical patent/BR112016012393A8/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/105—Delta proteobacteriales, e.g. Lawsonia; Epsilon proteobacteriales, e.g. campylobacter, helicobacter
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/52—Bacterial cells; Fungal cells; Protozoal cells
    • A61K2039/521—Bacterial cells; Fungal cells; Protozoal cells inactivated (killed)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525—Virus
    • A61K2039/5254—Virus avirulent or attenuated
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
    • A61K2039/552—Veterinary vaccine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants
    • A61K2039/55566—Emulsions, e.g. Freund's adjuvant, MF59
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/70—Multivalent vaccine
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011—Details
    • C12N2770/10011—Arteriviridae
    • C12N2770/10034—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein

Abstract

VACINA, E, USO DE UMA COMBINAÇÃO DE UM VÍRUS PRRS ATENUADO VIVO E UM ANTÍGENO DE LAWSONIA INTRACELLULARIS INATIVADO. A presente invenção se refere a uma vacina suína, em particular, uma vacina compreendendo em combinação vírus PRRS atenuado vivo e antígeno de Lawsonia intracellularis inativado, para a proteção de um suíno contra uma infecção com vírus PRRS e bactérias Lawsonia intracellularis. A invenção também se refere a um método para proteger um suíno contra uma infecção com vírus PRRS e bactérias Lawsonia intracellularis usando esta vacina.
BR112016012393A 2013-12-03 2014-12-02 vacina, e, uso de uma combinação de um vírus prrs atenuado vivo e um antígeno de lawsonia intracellularis inativado BR112016012393A8 (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP13195529 2013-12-03
PCT/EP2014/076243 WO2015082465A1 (en) 2013-12-03 2014-12-02 Swine vaccine against prrs and lawsonia intracellularis

Publications (2)

Publication Number Publication Date
BR112016012393A2 true BR112016012393A2 (pt) 2017-08-08
BR112016012393A8 BR112016012393A8 (pt) 2018-01-30

Family

ID=49680927

Family Applications (1)

Application Number Title Priority Date Filing Date
BR112016012393A BR112016012393A8 (pt) 2013-12-03 2014-12-02 vacina, e, uso de uma combinação de um vírus prrs atenuado vivo e um antígeno de lawsonia intracellularis inativado

Country Status (12)

Country Link
US (1) US20160303219A1 (pt)
EP (1) EP3076997B1 (pt)
JP (1) JP6484241B2 (pt)
KR (1) KR102360690B1 (pt)
CN (1) CN105873604B (pt)
BR (1) BR112016012393A8 (pt)
CA (1) CA2931139C (pt)
DK (1) DK3076997T3 (pt)
ES (1) ES2695172T3 (pt)
MX (1) MX371126B (pt)
RU (1) RU2655615C1 (pt)
WO (1) WO2015082465A1 (pt)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2018504423A (ja) * 2015-02-04 2018-02-15 インターベット インターナショナル ベー． フェー． 豚における無症候性ローソニア感染症に対する使用のためのワクチン
KR102632419B1 (ko) * 2016-12-23 2024-01-31 인터벳 인터내셔널 비.브이. 돼지용 조합 백신
RU2756767C2 (ru) 2017-04-13 2021-10-05 Интервет Интернэшнл Б.В. Вакцины, содержащие патогены свиней, для ассоциированного несмешанного применения
CN111676247A (zh) * 2020-06-30 2020-09-18 扬州大学 一株猪繁殖与呼吸综合征病毒1型分离株感染性克隆构建、拯救与应用

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU718333B2 (en) * 1995-11-30 2000-04-13 Agriculture Victoria Services Pty Ltd Therapeutic and diagnostic compositions
US6605696B1 (en) * 1999-10-22 2003-08-12 Pfizer, Inc. Lawsonia intracellularis proteins, and related methods and materials
AU2005306781B2 (en) * 2004-11-19 2011-12-22 Intervet International B.V. Porcine reproductive and respiratory syndrome virus strains and compositions
US8834891B2 (en) * 2005-03-14 2014-09-16 Boehringer Ingelheim Vetmedica, Inc. Immunogenic compositions comprising Lawsonia intracellularis
US8398994B2 (en) * 2005-07-15 2013-03-19 Boehringer Ingelheim Vetmedica, Inc. Lawsonia vaccine and methods of use thereof
WO2007116032A1 (en) * 2006-04-10 2007-10-18 Intervet International B.V. Vaccine against mycoplasma prrsv
US20100129397A1 (en) * 2006-12-11 2010-05-27 Boehringer Ingelheim Vetmedica, Inc. Effective method of treatment of porcine circovirus and lawsonia intracellularis infections
TWI551295B (zh) * 2008-04-18 2016-10-01 英特威特國際股份有限公司 防備胞內勞森菌（Ｌａｗｓｏｎｉａ ｉｎｔｒａｃｅｌｌｕｌａｒｉｓ）用疫苗
TWI449533B (zh) * 2008-04-18 2014-08-21 Intervet Int Bv 防備胞內勞森菌（Ｌａｗｓｏｎｉａ ｉｎｔｒａｃｅｌｌｕｌａｒｉｓ）、豬肺炎黴漿菌（Ｍｙｃｏｐｌａｓｍａ ｈｙｏｐｎｅｕｍｏｎｉａｅ）及豬環狀病毒（Ｐｏｒｃｉｎｅ ｃｉｒｃｏ ｖｉｒｕｓ）用疫苗
KR101653177B1 (ko) * 2008-08-25 2016-09-01 베링거잉겔하임베트메디카인코퍼레이티드 고병원성 돼지 생식기 및 호흡기 증후군(ｈｐ ｐｒｒｓ)에 대한 백신
JP2012506858A (ja) * 2008-10-23 2012-03-22 インターベット インターナショナル ベー． フェー． Ｌａｗｓｏｎｉａｉｎｔｒａｃｅｌｌｕｌａｒｉｓワクチン
UA114504C2 (uk) * 2012-04-04 2017-06-26 Зоетіс Сервісіз Ллс Комбінована вакцина pcv, mycoplasma hyopneumoniae та prrs

Also Published As

Publication number Publication date
BR112016012393A8 (pt) 2018-01-30
JP6484241B2 (ja) 2019-03-13
MX2016007226A (es) 2016-08-04
WO2015082465A1 (en) 2015-06-11
CA2931139A1 (en) 2015-06-11
MX371126B (es) 2020-01-17
US20160303219A1 (en) 2016-10-20
ES2695172T3 (es) 2019-01-02
EP3076997B1 (en) 2018-08-29
CN105873604B (zh) 2020-01-14
DK3076997T3 (en) 2018-12-10
CN105873604A (zh) 2016-08-17
CA2931139C (en) 2023-03-14
KR102360690B1 (ko) 2022-02-08
RU2655615C1 (ru) 2018-05-29
KR20160093048A (ko) 2016-08-05
EP3076997A1 (en) 2016-10-12
JP2017501985A (ja) 2017-01-19

Similar Documents

Publication Publication Date Title
BR112018013387A2 (pt) vetor de vacinação recombinante, vírus mva, vacina ou composição farmacêutica e kit
BRPI1013780A2 (pt) composições para imunização contra staphylococcus aureus.
CL2013002379A1 (es) Virus del sindrome reproductor y respiratorio porcino (prrsv); procedimiento para la preparacion del prrsv atenuado vivo; vacuna que lo comprende y su procedimiento de preparacion; y procedimiento para inmunizar cerdos contra el sindrome reproductor y respiratorio porcino.
CR20140437A (es) Vacuna de combinacion contra pcv/mycoplasma hyopneumoniae
BR112014024533A2 (pt) vacina contra mycoplasma hyopneumoniae
PH12017501370A1 (en) Bivalent swine influenza virus vaccine
DOP2011000268A (es) Vacuna inactivada del virus del dengue con un adjuvante libre de aluminio
CO6361948A2 (es) Uso de antigeno de mycoplasma bovis
EA201391515A1 (ru) Инактивированная вакцина вируса денге
MX2015010305A (es) Vacuna de combinacion para virus sincitial respiratorio e influenza.
NZ630831A (en) Compositions and methods for administration of vaccines against dengue virus
BR112018010679A2 (pt) métodos para tratar, prevenir e diagnosticar a infecção por vírus da diarréia epidêmica porcina
MX370584B (es) Vacuna contra lawsonia intracellularis y circovirus porcino 2.
BR112016012393A2 (pt) Vacina, e, uso de uma combinação de um vírus prrs atenuado vivo e um antígeno de lawsonia intracellularis inativado
CO7461133A2 (es) Parvovirus 5a porcino, métodos de uso y vacuna
UA116697C2 (uk) Композиція для запобігання зараженню видами роду mycoplasma
CO7461135A2 (es) Parvovirus porcino 5b, métodos de uso y vacuna
BR112018074910A2 (pt) composição imunológica, e, método de indução de uma resposta imunológica contra o vírus da influenza equina em um sujeito
MX2016002903A (es) Composiciones inmunogenas de la glicoproteina g de los virus hendra y nipah.
MX359103B (es) Composiciones y sus usos en el tratamiento de infecciones virales.
MX2017016401A (es) Composiciones inmunogenas.
PH12018501750A1 (en) Porcine reproductive and respiratory syndrome vaccine virus
BR112014023092A8 (pt) Composição imunogênica, método para a prevenção de infecção ou doença por hpv em um indivíduo, e, kit
BR112017025316A2 (pt) estratégia de vacina baseada em nanopartículas contra o vírus da gripe suína
BR112016012435A2 (pt) Vacina, e, usos de uma proteína orf2 recombinantemente expressada do circovírus porcino tipo 2

Legal Events

Date Code Title Description
B07D Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette]
B07G Grant request does not fulfill article 229-c lpi (prior consent of anvisa) [chapter 7.7 patent gazette]

Free format text: NOTIFICACAO DE DEVOLUCAO DO PEDIDO POR NAO SE ENQUADRAR NO ART. 229-C DA LPI.

B06U Preliminary requirement: requests with searches performed by other patent offices: procedure suspended [chapter 6.21 patent gazette]
B07A Application suspended after technical examination (opinion) [chapter 7.1 patent gazette]